| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.011 | 0.9 |